Endocannabinoid system alterations in Alzheimer's disease: A systematic review of human studies.

Berry, Alex J; Zubko, Olga; Reeves, Suzanne J; Howard, Robert J

Berry, Alex J; Zubko, Olga; Reeves, Suzanne J; Howard, Robert J.

Afiliação

Berry AJ; Division of Psychiatry, University College London, London, UK. Electronic address: alex.berry3@nhs.net.
Zubko O; Division of Psychiatry, University College London, London, UK.
Reeves SJ; Division of Psychiatry, University College London, London, UK.
Howard RJ; Division of Psychiatry, University College London, London, UK.

Brain Res ; 1749: 147135, 2020 12 15.

Article em En | MEDLINE | ID: mdl-32980333

Assuntos

Doença de Alzheimer/metabolismo; Endocanabinoides/metabolismo; Receptores de Canabinoides/metabolismo; Amidoidrolases/metabolismo; Ácidos Araquidônicos/metabolismo; Disfunção Cognitiva/metabolismo; Humanos; Monoacilglicerol Lipases/metabolismo; Alcamidas Poli-Insaturadas/metabolismo

Palavras-chave

2-arachidonoylglycerol; Alzheimer; Anandamide; Cannabinoid receptor; Endocannabinoid; Fatty acid amide hydrolase; Monoacylglycerol; Neurodegeneration; TRPV1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Canabinoides / Endocanabinoides / Doença de Alzheimer Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google